ADAR1 Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History

ADAR1 Capital Management’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$442K	Hold	167,941	–	–	0.02%	219
2026 Q1	$324K	Hold	167,941	–	–	0.02%	234
2025 Q4	$331K	Hold	167,941	–	–	0.02%	207
2025 Q3	$467K	Buy	167,941 +830	+0.5%	+$2.28K	0.04%	141
2025 Q2	$481K	Sell	167,111 -27,554	-14%	-$84K	0.07%	121
2025 Q1	$586K	Sell	194,665 -5,556	-3%	-$19.3K	0.11%	98
2024 Q4	$661K	Buy	200,221 +3,670	+2%	+$12.7K	0.13%	102
2024 Q3	$719K	Buy	196,551 +23,955	+14%	+$93.5K	0.12%	97
2024 Q2	$725K	Buy	172,596 +50,374	+41%	+$235K	0.14%	79
2024 Q1	$777K	Buy	+122,222	New	+$683K	0.18%	70

Other funds holding KPRX

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

ADAR1 Capital Management's KPRX Position: Q2 2026 in Review

ADAR1 Capital Management held its Kiora Pharmaceuticals (KPRX) position steady in Q2 2026 at 167,941 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #219.

ADAR1 Capital Management first reported a position in KPRX in Q1 2024 and has held it in 10 quarters since. The position peaked at $777K in Q1 2024. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

ADAR1 Capital Management held 167,941 shares of Kiora Pharmaceuticals worth $442K as of Q2 2026.
ADAR1 Capital Management left its Kiora Pharmaceuticals share count unchanged in Q2 2026.
Kiora Pharmaceuticals made up 0.02% of ADAR1 Capital Management's portfolio in Q2 2026, its #219 holding.
ADAR1 Capital Management first reported a position in Kiora Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
ADAR1 Capital Management's Kiora Pharmaceuticals position peaked at $777K in Q1 2024.
22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.